{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28611093", "DateCompleted": {"Year": "2017", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2017", "Month": "06", "Day": "13"}], "ELocationID": ["10.1124/jpet.117.240705"], "Journal": {"ISSN": "1521-0103", "JournalIssue": {"Volume": "362", "Issue": "2", "PubDate": {"Year": "2017", "Month": "Aug"}}, "Title": "The Journal of pharmacology and experimental therapeutics", "ISOAbbreviation": "J Pharmacol Exp Ther"}, "ArticleTitle": "Danirixin: A Reversible and Selective Antagonist of the CXC Chemokine Receptor 2.", "Pagination": {"StartPage": "338", "EndPage": "346", "MedlinePgn": "338-346"}, "Abstract": {"AbstractText": ["CXC chemokine receptor 2 (CXCR2) is a key receptor in the chemotaxis of neutrophils to sites of inflammation. The studies reported here describe the pharmacological characterization of danirixin, a CXCR2 antagonist in the diaryl urea chemical class. Danirixin has high affinity for CXCR2, with a negative log of the 50% inhibitory concentration (pIC<sub>50</sub>) of 7.9 for binding to Chinese hamster ovary cell (CHO)-expressed human CXCR2, and 78-fold selectivity over binding to CHO-expressed CXCR1. Danirixin is a competitive antagonist against CXCL8 in Ca<sup>2+</sup>-mobilization assays, with a K<sub>B</sub> (the concentration of antagonist that binds 50% of the receptor population) of 6.5 nM and antagonist potency (pA<sub>2</sub>) of 8.44, and is fully reversible in washout experiments over 180 minutes. In rat and human whole-blood studies assessing neutrophil activation by surface CD11b expression following CXCL2 (rat) or CXCL1 (human) challenge, danirixin blocks the CD11b upregulation with pIC<sub>50</sub>s of 6.05 and 6.3, respectively. Danirixin dosed orally also blocked the influx of neutrophils into the lung in vivo in rats following aerosol lipopolysaccharide or ozone challenge, with median effective doses (ED<sub>50</sub>s) of 1.4 and 16 mg/kg respectively. Thus, danirixin would be expected to block chemotaxis in disease states in which neutrophils are increased in response to inflammation, such as pulmonary diseases. In comparison with navarixin, a CXCR2 antagonist from a different chemical class, the binding characterization of danirixin is distinct. These observations may offer insight into the previously observed clinical differences in induction of neutropenia between these compounds."], "CopyrightInformation": "Copyright \u00a9 2017 by The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Busch-Petersen", "ForeName": "Jakob", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Carpenter", "ForeName": "Donald C", "Initials": "DC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Burman", "ForeName": "Miriam", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Foley", "ForeName": "James", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Hunsberger", "ForeName": "Gerald E", "Initials": "GE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Kilian", "ForeName": "David J", "Initials": "DJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Salmon", "ForeName": "Michael", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Mayer", "ForeName": "Ruth J", "Initials": "RJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA."}], "LastName": "Yonchuk", "ForeName": "John G", "Initials": "JG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "GSK R&D, King of Prussia PA Ruth.M.Tal-Singer@gsk.com."}], "LastName": "Tal-Singer", "ForeName": "Ruth", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Pharmacol Exp Ther", "NlmUniqueID": "0376362", "ISSNLinking": "0022-3565"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperidines"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Interleukin-8B"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfones"}, {"RegistryNumber": "R318PGH5VP", "NameOfSubstance": "danirixin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "CHO Cells"}, {"QualifierName": [], "DescriptorName": "Cricetinae"}, {"QualifierName": [], "DescriptorName": "Cricetulus"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Interleukin-8"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Piperidines"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Inbred Lew"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Receptors, Interleukin-8B"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfones"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "2", "Day": "15"}, {"Year": "2017", "Month": "6", "Day": "9"}, {"Year": "2017", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28611093", "10.1124/jpet.117.240705", "jpet.117.240705"]}}], "PubmedBookArticle": []}